Please login to the form below

Not currently logged in
Email:
Password:

Movember

This page shows the latest Movember news and features for those working in and with pharma, biotech and healthcare.

Beard growing challenge to raise money for prostate cancer

Beard growing challenge to raise money for prostate cancer

Several facial hair challenges have emerged in recent years since the huge success of Movember, which encourages men to grow moustaches for the month of November. ... The organisers of OctoBeardFest stressed the differences between the goals of its

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Latest Intelligence

  • Hacking Innovation Hacking Innovation

    The idea was inspired by “new technologies that are emerging in the fabric space,” said team one’s Kirsty Wood, who is also digital marketing manager for the Movember Foundation.

More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.

Latest from PMHub

More from PMHub
Approximately 0 fully matching, plus 1 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Six Degrees Medical Consulting

Partnering with top global pharmaceutical companies, we push the boundaries to create meaningful, impactful and lasting learning opportunities. We leverage...

Latest intelligence

Report: Achieving launch excellence in the challenging healthcare markets of today
Our in-depth report is based on original data and expert interviews, which coupled with our own experience, ensures we give you the best recommendations for achieving launch success in challenging...
What is blockchain and why should i care - Richard Springham
Four Health - Emerging Technologies The power of blockchain lies in the fact it can prove that a unique event occurred at a certain time with out the need to...
NHS medicines optimisation milestone
Steve How, Paul Midgley and Oli Hudson, of the Wilmington Healthcare Consulting Team, explore the implications of Adalimumab’s recent European patent expiry...

Infographics